Growth Metrics

Legend Biotech (LEGN) Change in Working Capital (2024 - 2025)

Legend Biotech (LEGN) posted Change in Working Capital of -$1.7 million for Q3 2025, down 166.29% on a QoQ basis from -$620000.0 in Q3 2024, and down 166.29% year-over-year from $2.5 million in Q3 2024.

Legend Biotech (LEGN) has 2 years of Change in Working Capital data on file, last reported at -$1.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -1.65 Mn
Sep 30, 2025 -1.65 Mn
Sep 30, 2024 -620,000.00
Sep 30, 2024 -620,000.00